Which has grown faster, GYRE or INMD?

Over the past five years, GYRE grew revenue faster — GYRE at a 84.92% CAGR versus INMD at 5.42%.

Is GYRE or INMD more profitable?

INMD runs the higher net margin — GYRE at -14.52% versus INMD at 20.69%.

How have GYRE and INMD total returns compared?

Over the past 5 years, GYRE delivered -0.34% and INMD delivered -27.48% annualized total return. Past performance doesn't predict future results.

Gyre Therapeutics, Inc. (GYRE) vs InMode Ltd. (INMD)

A side-by-side comparison of Gyre Therapeutics, Inc. and InMode Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

GYRE

Gyre Therapeutics, Inc.

$817M

$7.33HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT

INMD

InMode Ltd.

$810M

$14.09HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT

Total return — GYRE vs INMD

growth of $100 · dividends reinvested · last 7y

GYRE -58.4% (-11.8%/yr)INMD +108.1% (+11.0%/yr)INMD compounded faster over this window

Log scale — wide-divergence pair

GYRE INMD

GYRE vs INMD: by the numbers

•GYRE is the larger company ($817M vs $810M market cap).
•INMD is profitable (20.69% net margin) while GYRE runs a net loss (-14.52%).
•GYRE grew revenue faster over the past five years (84.92% vs 5.42% CAGR).

Metrics side by side

Valuation

Metric	GYRE	INMD
P/E ratio	N/A	11.45
Forward P/E	N/A	10.87
PEG ratio	N/A	1.15
P/S ratio	6.85	2.16
P/B ratio	7.57	1.29
EV / EBITDA	N/A	5.98
FCF yield	N/A	10.80%

Profitability

Metric	GYRE	INMD
Gross margin	94.30%	76.52%
Operating margin	9.86%	18.47%
Net margin	-14.52%	20.69%
ROE	-13.30%	12.32%
ROIC	-9.77%	9.20%

Growth (annualized)

Metric	GYRE	INMD
Revenue CAGR (5Y)	84.92%	5.42%
EPS CAGR (5Y)	N/A	6.87%
FCF CAGR (5Y)	N/A	1.36%
Total return CAGR (5Y)	-0.34%	-27.48%

Frequently asked

Which has grown faster, GYRE or INMD?: Over the past five years, GYRE grew revenue faster — GYRE at a 84.92% CAGR versus INMD at 5.42%.
Is GYRE or INMD more profitable?: INMD runs the higher net margin — GYRE at -14.52% versus INMD at 20.69%.
How have GYRE and INMD total returns compared?: Over the past 5 years, GYRE delivered -0.34% and INMD delivered -27.48% annualized total return. Past performance doesn't predict future results.

Go deeper

Full GYRE analysis Full INMD analysis Interactive comparison tool

Dig into the metrics

InMode P/E ratio Gyre Therapeutics ROE InMode ROE Gyre Therapeutics operating margin InMode operating margin Gyre Therapeutics revenue growth InMode revenue growth Gyre Therapeutics free cash flow InMode free cash flow

Gyre Therapeutics & InMode appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.